Stay updated with breaking news from Nasdaq Fbio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Fortress Biotech, Inc. (NASDAQ:FBIO – Get Free Report) CEO Lindsay A. Md Rosenwald acquired 1,567,515 shares of the firm’s stock in a transaction dated Tuesday, November 14th. The shares were purchased at an average cost of $1.70 per share, for a total transaction of $2,664,775.50. Following the completion of the acquisition, the chief executive officer […]
Total consolidated net revenue was $34.8 million in the third quarter of 2023, a 100% increase from total consolidated net revenue of $17.4 million in the...
MIAMI, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an innovative biopharmaceutical company focused...
MIAMI, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an innovative biopharmaceutical company focused...
StockNews.com started coverage on shares of Fortress Biotech (NASDAQ:FBIO – Free Report) in a report published on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, Cantor Fitzgerald reaffirmed an overweight rating and set a $75.00 price target on shares of Fortress Biotech in a research report on Tuesday, August […]